位置:首页 > 蛋白库 > PMYT1_DROME
PMYT1_DROME
ID   PMYT1_DROME             Reviewed;         533 AA.
AC   Q9NI63; Q961T4; Q9VRP6;
DT   23-NOV-2004, integrated into UniProtKB/Swiss-Prot.
DT   23-NOV-2004, sequence version 2.
DT   03-AUG-2022, entry version 157.
DE   RecName: Full=Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase;
DE            EC=2.7.11.1;
DE   AltName: Full=Myt1 kinase;
DE   AltName: Full=dMyt1;
GN   Name=Myt1; ORFNames=CG32417;
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota;
OC   Neoptera; Endopterygota; Diptera; Brachycera; Muscomorpha; Ephydroidea;
OC   Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=11882391; DOI=10.1016/s0898-6568(01)00276-5;
RA   Cornwell W.D., Kaminski P.J., Jackson J.R.;
RT   "Identification of Drosophila Myt1 kinase and its role in Golgi during
RT   mitosis.";
RL   Cell. Signal. 14:467-476(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], AND FUNCTION.
RX   PubMed=12072468; DOI=10.1093/genetics/161.2.721;
RA   Price D.M., Jin Z., Rabinovitch S., Campbell S.D.;
RT   "Ectopic expression of the Drosophila Cdk1 inhibitory kinases, Wee1 and
RT   Myt1, interferes with the second mitotic wave and disrupts pattern
RT   formation during eye development.";
RL   Genetics 161:721-731(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley;
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X., Brandon R.C.,
RA   Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D., Wan K.H., Doyle C.,
RA   Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G., Abril J.F., Agbayani A.,
RA   An H.-J., Andrews-Pfannkoch C., Baldwin D., Ballew R.M., Basu A.,
RA   Baxendale J., Bayraktaroglu L., Beasley E.M., Beeson K.Y., Benos P.V.,
RA   Berman B.P., Bhandari D., Bolshakov S., Borkova D., Botchan M.R., Bouck J.,
RA   Brokstein P., Brottier P., Burtis K.C., Busam D.A., Butler H., Cadieu E.,
RA   Center A., Chandra I., Cherry J.M., Cawley S., Dahlke C., Davenport L.B.,
RA   Davies P., de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I.,
RA   Dietz S.M., Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C.,
RA   Dunn P., Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S.,
RA   Fleischmann W., Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M.,
RA   Glasser K., Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J., Hostin D.,
RA   Houston K.A., Howland T.J., Wei M.-H., Ibegwam C., Jalali M., Kalush F.,
RA   Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A., Kimmel B.E., Kodira C.D.,
RA   Kraft C.L., Kravitz S., Kulp D., Lai Z., Lasko P., Lei Y., Levitsky A.A.,
RA   Li J.H., Li Z., Liang Y., Lin X., Liu X., Mattei B., McIntosh T.C.,
RA   McLeod M.P., McPherson D., Merkulov G., Milshina N.V., Mobarry C.,
RA   Morris J., Moshrefi A., Mount S.M., Moy M., Murphy B., Murphy L.,
RA   Muzny D.M., Nelson D.L., Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R.,
RA   Pacleb J.M., Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V.,
RA   Reese M.G., Reinert K., Remington K., Saunders R.D.C., Scheeler F.,
RA   Shen H., Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E., Svirskas R.,
RA   Tector C., Turner R., Venter E., Wang A.H., Wang X., Wang Z.-Y.,
RA   Wassarman D.A., Weinstock G.M., Weissenbach J., Williams S.M., Woodage T.,
RA   Worley K.C., Wu D., Yang S., Yao Q.A., Ye J., Yeh R.-F., Zaveri J.S.,
RA   Zhan M., Zhang G., Zhao Q., Zheng L., Zheng X.H., Zhong F.N., Zhong W.,
RA   Zhou X., Zhu S.C., Zhu X., Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M.,
RA   Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [4]
RP   GENOME REANNOTATION.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q., Stapleton M.,
RA   Yamada C., Ashburner M., Gelbart W.M., Rubin G.M., Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a systematic
RT   review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 3-533.
RC   STRAIN=Berkeley; TISSUE=Head;
RX   PubMed=12537569; DOI=10.1186/gb-2002-3-12-research0080;
RA   Stapleton M., Carlson J.W., Brokstein P., Yu C., Champe M., George R.A.,
RA   Guarin H., Kronmiller B., Pacleb J.M., Park S., Wan K.H., Rubin G.M.,
RA   Celniker S.E.;
RT   "A Drosophila full-length cDNA resource.";
RL   Genome Biol. 3:RESEARCH0080.1-RESEARCH0080.8(2002).
RN   [6]
RP   FUNCTION.
RX   PubMed=15581871; DOI=10.1016/j.ydbio.2004.08.043;
RA   Fichelson P., Gho M.;
RT   "Mother-daughter precursor cell fate transformation after Cdc2 down-
RT   regulation in the Drosophila bristle lineage.";
RL   Dev. Biol. 276:367-377(2004).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-504 AND SER-519, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Embryo;
RX   PubMed=18327897; DOI=10.1021/pr700696a;
RA   Zhai B., Villen J., Beausoleil S.A., Mintseris J., Gygi S.P.;
RT   "Phosphoproteome analysis of Drosophila melanogaster embryos.";
RL   J. Proteome Res. 7:1675-1682(2008).
CC   -!- FUNCTION: Acts as a negative regulator of entry into mitosis (G2 to M
CC       transition) by phosphorylation of Cdk1 specifically when Cdk1 is
CC       complexed to cyclins (PubMed:11882391, PubMed:12072468,
CC       PubMed:15581871). Mediates phosphorylation of Cdk1 predominantly on
CC       'Thr-14' (PubMed:11882391). Also involved in Golgi fragmentation
CC       (PubMed:11882391). May be involved in phosphorylation of Cdk1 on 'Tyr-
CC       15' to a lesser degree, however tyrosine kinase activity is unclear and
CC       may be indirect (PubMed:11882391). May be a downstream target of Notch
CC       signaling pathway during eye development (PubMed:12072468).
CC       {ECO:0000269|PubMed:11882391, ECO:0000269|PubMed:12072468,
CC       ECO:0000269|PubMed:15581871}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1;
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus membrane
CC       {ECO:0000305|PubMed:11882391}; Peripheral membrane protein
CC       {ECO:0000305|PubMed:11882391}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr protein
CC       kinase family. WEE1 subfamily. {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAF32288.1; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=AAK77309.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF215861; AAF32288.1; ALT_FRAME; mRNA.
DR   EMBL; AE014296; AAF50747.3; -; Genomic_DNA.
DR   EMBL; AY047577; AAK77309.1; ALT_INIT; mRNA.
DR   RefSeq; NP_647987.2; NM_139730.3.
DR   AlphaFoldDB; Q9NI63; -.
DR   SMR; Q9NI63; -.
DR   BioGRID; 64110; 9.
DR   STRING; 7227.FBpp0076824; -.
DR   iPTMnet; Q9NI63; -.
DR   PaxDb; Q9NI63; -.
DR   PRIDE; Q9NI63; -.
DR   EnsemblMetazoa; FBtr0077118; FBpp0076824; FBgn0040298.
DR   GeneID; 38649; -.
DR   KEGG; dme:Dmel_CG32417; -.
DR   CTD; 4661; -.
DR   FlyBase; FBgn0040298; Myt1.
DR   VEuPathDB; VectorBase:FBgn0040298; -.
DR   eggNOG; KOG0601; Eukaryota.
DR   GeneTree; ENSGT00940000159427; -.
DR   HOGENOM; CLU_028362_0_0_1; -.
DR   InParanoid; Q9NI63; -.
DR   OMA; SHFEQCF; -.
DR   OrthoDB; 1063695at2759; -.
DR   PhylomeDB; Q9NI63; -.
DR   Reactome; R-DME-156711; Polo-like kinase mediated events.
DR   Reactome; R-DME-69273; Cyclin A/B1/B2 associated events during G2/M transition.
DR   Reactome; R-DME-69478; G2/M DNA replication checkpoint.
DR   BioGRID-ORCS; 38649; 0 hits in 3 CRISPR screens.
DR   GenomeRNAi; 38649; -.
DR   PRO; PR:Q9NI63; -.
DR   Proteomes; UP000000803; Chromosome 3L.
DR   Bgee; FBgn0040298; Expressed in oocyte and 20 other tissues.
DR   Genevisible; Q9NI63; DM.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004672; F:protein kinase activity; IBA:GO_Central.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0004712; F:protein serine/threonine/tyrosine kinase activity; IDA:UniProtKB.
DR   GO; GO:0007143; P:female meiotic nuclear division; IMP:FlyBase.
DR   GO; GO:0000086; P:G2/M transition of mitotic cell cycle; IMP:UniProtKB.
DR   GO; GO:0048142; P:germarium-derived cystoblast division; IMP:FlyBase.
DR   GO; GO:0007140; P:male meiotic nuclear division; IMP:FlyBase.
DR   GO; GO:0051321; P:meiotic cell cycle; IMP:FlyBase.
DR   GO; GO:0045930; P:negative regulation of mitotic cell cycle; IMP:UniProtKB.
DR   GO; GO:0045793; P:positive regulation of cell size; IGI:FlyBase.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0048137; P:spermatocyte division; IMP:FlyBase.
DR   GO; GO:0007284; P:spermatogonial cell division; IMP:FlyBase.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR016235; Tyr/Thr_kinase_Cdc2_inhib.
DR   Pfam; PF00069; Pkinase; 1.
DR   PIRSF; PIRSF000567; TYPK_Myt1; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Cell cycle; Golgi apparatus; Kinase; Magnesium; Membrane;
KW   Metal-binding; Nucleotide-binding; Phosphoprotein; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN           1..533
FT                   /note="Membrane-associated tyrosine- and threonine-specific
FT                   cdc2-inhibitory kinase"
FT                   /id="PRO_0000086577"
FT   DOMAIN          102..351
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          1..35
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1..25
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        224
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         108..116
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         131
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         229
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250"
FT   BINDING         243
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         504
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:18327897"
FT   MOD_RES         519
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:18327897"
SQ   SEQUENCE   533 AA;  61131 MW;  3DCD3458914D0645 CRC64;
     MEKHHRLPLP ELHDDKHRHK QCNGENSNRF RPPKYKTRGY VAVDNNNLNR SQSLGSCSTN
     SSQIAHAISF RDAGCSDSST LPSSPVQAEL STLSLSHFEQ CFERLAKLGE GSFGEVFQVR
     DRSDGQLYAV KISKQLFRGE QYRAERLEEV RRYEEFSGHE NCIRFIRAWE QYDRLYMQME
     LCRESLEQYL LRCQRIPEER IWHILLDLLR GLKSLHDRNL IHLDIKLDNV LIGEDDETCK
     LADFGLVIDV DRANSHHATE GDSRYMAPEI LQGHFSKAAD IFSLGIAMLE LACYMDLPSN
     GPLWHELRHG ILPEEFINKI SLELQSVIKS MMKPDPAQRP TAEQLLSHPK LQYLQKKRKS
     LMNFSMLSRS FRRSRRAVWG RMCNWKTAAF RYLLYFLEVL HLCKPITASQ PNINIVPSSP
     SSKGVPLVPQ VEFQLVGSTP IANRDCYASD FLSGEDPLDL SNQGSPNVIN STPLNTNQGK
     SRLDLLKNNV DSMGRYVHVH DFESPCSALS SAKVLDTSSF RRKKLFVLEY DDE
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024